Continuing story · 1 report

NSW September unauthorized-peptide emergency visits

First aired Latest aired

Developing

Where it stands

By October 19, 2026, New South Wales had recorded more than 217 peptide-associated emergency-department presentations in September, within 1,180 presentations over a 15-month surveillance period. Health officials warned that unapproved products may not match their labels and advised using peptides only when prescribed by a GP; whether the September rise has subsided or the response has closed remains open.

Explore with HeyDex

Follow via RSS

Story trackerDay 1

1 report11 outlets25 sources1 video

  • No dated events yet
  1. Update 1NSW records 1,180 peptide-linked emergency visits amid warnings on online products

The story so far

  1. Update 1

    NSW records 1,180 peptide-linked emergency visits amid warnings on online products

    Fifteen months of NSW surveillance show a sharp rise in emergency presentations associated with peptide use. The warning concerns unapproved products—not every peptide medicine.

    Still open after this report

    • The surveillance does not identify the products involved, their verified contents, the number of distinct patients or how many suffered lasting injury.

History

  1. Opened1 report

Who's involved

Organizations

  • Ministry of Healthministry in New South Wales, Australia1 report
  • Therapeutic Goods Administrationregulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia1 report

Places

  • New South WalesNew South Wales, Australia1 report

Every outlet we read on this story

25 sources11 outlets1 video